Answers are grounded in this paper and cite their sources.
Overviews of randomized clinical trials have established that the survival rate after breast-conserving surgery (partial mastectomy) is equivalent to that after mastectomy1 and that local control of disease and breast cancer–specific survival rates are related: strategies that reduce the rates of local recurrence at 5 years and 10 years translate into an improved breast cancer–specific survival rate at 15 years.2 This year in the United States, nearly 270,000 women will receive a diagnosis of operable breast cancer; a substantial majority of these women will be suitable candidates for breast-conserving surgery, and approximately two thirds (180,000 women) will choose this option. . . .
No takes yet. Share an insight, caveat, or question.
Cody et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: